Mizuho Issues Positive Forecast for Corteva (NYSE:CTVA) Stock Price

Corteva (NYSE:CTVA) had its target price raised by Mizuho from $96.00 to $97.00 in a research note released on Tuesday, Marketbeat.com reports. Mizuho currently has an outperform rating on the stock.

Several other brokerages also recently issued reports on CTVA. CICC Research lifted their price objective on Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Deutsche Bank Aktiengesellschaft increased their target price on Corteva from $90.00 to $100.00 in a report on Monday, May 11th. UBS Group cut their price target on Corteva from $90.00 to $86.00 and set a “neutral” rating for the company in a report on Tuesday, June 9th. Royal Bank Of Canada lifted their price target on Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. Finally, Barclays upped their price target on shares of Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a research report on Thursday, June 11th. Thirteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $88.95.

Corteva Stock Performance

NYSE CTVA opened at $84.91 on Tuesday. Corteva has a 1-year low of $60.53 and a 1-year high of $87.69. The company has a 50 day moving average of $80.53 and a 200-day moving average of $77.87. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The firm has a market cap of $56.79 billion, a price-to-earnings ratio of 49.95, a PEG ratio of 2.63 and a beta of 0.56.

Corteva (NYSE:CTVA) last announced its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.18 by $0.32. The business had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.Corteva’s revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts forecast that Corteva will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were issued a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.8%. The ex-dividend date was Monday, June 1st. Corteva’s dividend payout ratio is currently 42.35%.

Hedge Funds Weigh In On Corteva

A number of hedge funds and other institutional investors have recently bought and sold shares of CTVA. Tema ETFs LLC raised its position in shares of Corteva by 10.4% during the 2nd quarter. Tema ETFs LLC now owns 10,774 shares of the company’s stock valued at $912,000 after acquiring an additional 1,015 shares during the last quarter. City Holding Co. lifted its stake in shares of Corteva by 2.6% in the 2nd quarter. City Holding Co. now owns 25,086 shares of the company’s stock valued at $2,124,000 after purchasing an additional 635 shares during the period. Sax Wealth Advisors LLC bought a new position in shares of Corteva in the 2nd quarter worth $237,000. Avity Investment Management Inc. boosted its position in shares of Corteva by 14.4% in the 2nd quarter. Avity Investment Management Inc. now owns 5,172 shares of the company’s stock worth $438,000 after purchasing an additional 650 shares during the last quarter. Finally, Valeo Financial Advisors LLC grew its stake in shares of Corteva by 8.3% during the second quarter. Valeo Financial Advisors LLC now owns 6,963 shares of the company’s stock worth $589,000 after purchasing an additional 536 shares during the period. 81.54% of the stock is owned by institutional investors.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.